Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5− TH2 responses
Received 12 May 2009; received in revised form 29 September 2009; accepted 30 September 2009.
Background
Both anaphylactic food allergy and eosinophil-associated gastrointestinal disorders are associated with TH2 responses and food-specific IgE, yet they have very different clinical presentations.
Objective
To determine whether the clinical differences between anaphylactic food allergy and eosinophil-associated gastrointestinal disorders are reflected in different TH2 responses to foods.
Methods
Subjects with peanut allergy (PA), subjects with allergic eosinophilic gastroenteritis (AEG), and nonatopic subjects were enrolled. Antigen-specific IL-4, IL-5, IFN-γ, and TNF T-cell responses to peanut, soy, and shrimp were measured by using intracellular cytokine staining and polychromatic flow cytometry.
Results
Two distinct subpopulations of TH2 cells were found: IL-5+ TH2 (IL-4+, IL-5+) and IL-5– TH2 (IL-4+, IL-5–) cells. Peanut-specific IL-5+ TH2 cells were present at a 20-fold greater frequency in AEG versus PA (81 vs 4 per 106 CD4 cells; P = .05), whereas there were similar frequencies of IL-5- TH2 cells (67 vs 41 per 106). For all foods, IL-5+ TH2 cells accounted for a significantly greater fraction of the antigen-specific cells in AEG relative to PA (29% vs 4%; P < .0001). In PA but not AEG, IL-5– TH2 responses to peanut were highly correlated with peanut-specific IgE (r = 0.87 vs 0.55, respectively). All subject groups elicited similar very low-magnitude TH1 responses to food antigens.
Conclusion
TH2 responses are composed of 2 subpopulations: IL-5+ TH2 and IL-5– TH2 cells. IL-5+ TH2 food allergen–specific T cells are singularly associated with AEG, whereas PA is associated with a dominant IL-5– TH2 response. These results suggest heterogeneity within the TH2 cytokine response, with different TH2 responses alternatively favoring IgE-mediated or eosinophil-dominant immunopathology.
Disclosure of potential conflict of interest: C. Prussin owned stock in Affymetrix and receives research support from NIAID/NIH. The rest of the authors have declared that they have no conflict of interest.